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INTRODUCTION 
Sylimarin, the active substance of Sylibum 
Marianum has a well-known 
hepatoprotective effect (1). The result of 
extraction process of the Sylibum 
Marianum seed were 25% oil and a dry, 
water insoluble sylimarin extract. The aim 
of the study was to prepare sylimarin 
formulations with high bioavailability for 
the treatment of acut hepatotoxicity. Water 
miscible self micro emulsifying drug 
delivery systems (SMEDDS) (2) of the oil 
and water soluble formulations of 
sylimarin were produced which are 
suitable for further in vitro and in vivo 
examinations. 
 
MATERIALS AND METHODS 
 
Materials 
Sylibum Marianum seed oil and sylimarin 
were originated from Sylibum Marianum 
seeds. Hydroxylpropyl-β-cyclodextrin 
(HPBCD), randomly methylated β-
cyclodextrin (RAMEB) and 2,6-di-O-
methyl β-cyclodextrin (DIMEB) were the 
product of Cyclolab Ltd. (Hungary), 
Labrasol
®
 was a kind gift of Gattefosse 
(France), while all other reagents 
purchased from Sigma. 
 
Methods 
Sylibum Marianum seed oil was 
incorporated into SMEDDS, using 
Labrasol. Cyclodextrin-sylimarin 
complexes were produced by kneading 
method (3). The weight ratio of 
cylodextrins and sylimarin was 10:1 in the 
mixtures. The UV-spectra of the solutions 
were recorded by Shimadzu UV-1601 
spectrofotometer. 
 
RESULTS AND DISCUSSION 
 
To increase the bioavailability of Sylibum 
Marianum seed oil we produced different 
SMEEDS compositions. The emulsifying 
agent (Labrasol) content and the oil 
content of SMEEDS varied between 60-
80% and 10-30% respectively. Each 
system remained stable in 10, 100 and 
1000 times dilutions in water. The 
diameter of the dispersed oil phase was in 
micrometer range as confirmed by 
microscopic investigation. 
Excess amount of cyclodextrin-sylimarin 
mixtures were dissolved in water until 
equilibrium is reached between the 
unsolved and dissolved phases and the 
UV-spectra of the filtered solutions were 
recorded. All of the cyclodextrins 
(HPBCD, RAMEB and DIMEB) were able 
to solubilise sylimarin, but DIMEB had the 
greatest ability for the complexation (Fig. 
1.) 
 
 
Fig. 1: UV-spectra of different cyclodextrin-sylimarin 
complexes. 
 
CONCLUSIONS 
Stable Sylibum Marianum seed oil 
SMEDDS; HPBCD, RAMEB and DIMEB 
water soluble sylimarin complexes were 
produced. The products are suitable for 
further safety and effectiveness 
examinations. 
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